Two of AstraZeneca’s top cancer treatments have been approved in combination to treat a subgroup of endometrial cancer patients in the European Union, the drugmaker …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.